Metallic silver fragments cause massive tissue loss in the mouse brain

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 1, 2011, Pages 1-10

  Locht, Linda Jansons ^a   Pedersen, Mie O ^b   Markholt, Sara ^a   Bibby, Bo Martin ^a   Larsen, Agnete ^a   Penkowa, Milena ^b   Stoltenberg, Meredin ^a   Rungby, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; METAL; METALLOTHIONEIN I; METALLOTHIONEIN II; SILVER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANIMAL WELFARE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; AUTOMETALLOGRAPHY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN NERVE CELL; BRAIN TISSUE; BRAIN VENTRICLE; CELL COUNT; CHOROID PLEXUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCEPHALITIS; EPENDYMA CELL; EXPOSURE; FEMALE; GLIA CELL; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KIDNEY; LYSOSOME; MOUSE; NERVOUS TISSUE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOTACTIC PROCEDURE;

ANIMALS; BRAIN; CELL COUNT; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; METALLOTHIONEIN; MICE; MICE, INBRED BALB C; PROSTHESES AND IMPLANTS; SILVER; STEREOTAXIC TECHNIQUES; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 79958859539     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00668.x     Document Type: Article

References (65)

1. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003;98:725-30.
2. Fox CL Jr, Rappole BW, Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet 1969;128:1021-6.
3. Modak SM, Fox CL Jr. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973;22:2391-404.
4. Brett DW. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage 2006;52:34-41.
5. Suska F, Svensson S, Johansson A, Emanuelsson L, Karlholm H, Ohrlander M et al. In vivo evaluation of noble metal coatings. J Biomed Mater Res B Appl Biomater 2010;92:86-94.
6. Bayston R, Vera L, Mills A, Ashraf W, Stevenson O, Howdle SM. In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J Antimicrob Chemother 2010;65:258-65.
7. Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care 2008;8:360-5.
8. Sudmann E, Vik H, Rait M, Todnem K, Andersen KJ, Julsham K et al. Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med Prog Technol 1994;20:179-84.
9. Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingeldein E et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004;25:4383-91.
10. Gamelli RL, Paxton TP, O'Reilly M. Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet 1993;177:115-20.
11. Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006;3:282-94.
12. Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2008;33:17-34.
13. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett 2008;176:1-12.
14. Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bull NYU Hosp Jt Dis 2009;67:182-8.
15. Cannon GJ, Swanson JA. The macrophage capacity for phagocytosis. J Cell Sci 1992;101:907-13.
16. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 1998;19:2297-302.
17. Danscher G, Locht LJ. In vivo liberation of silver ions from metallic silver surfaces. Histochem Cell Biol 2010;133:359-66.
18. Locht LJ, Larsen A, Stoltenberg M, Danscher G. Cultured macrophages cause dissolucytosis of metallic silver. Histol Histopathol 2009;24:167-73.
19. Larsen A, Stoltenberg M, Danscher G. In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces. Histochem Cell Biol 2007;128:1-6.
20. Danscher G. Light and electron microscopic localization of silver in biological tissue. Histochemistry 1981;71:177-86.
21. Danscher G, Stoltenberg M. Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem 2006; 41:57-139.
22. Kristiansen S, Ifversen P, Danscher G. Ultrastructural localization and chemical binding of silver ions in human organotypic skin cultures. Histochem Cell Biol 2008;130:177-84.
23. Petering H. Pharmacology and toxicology of heavy metals: silver. Pharmac Ther A 1976;1:127-30.
24. Aaseth J, Olsen A, Halse J, Hovig T. Argyria-tissue deposition of silver as selenide. Scand J Clin Lab Invest 1981;41:247-51.
25. Wadhera A, Fung M. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J 2005;11:12.
26. Drake PL, Hazelwood KJ. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 2005;49:575-85.
27. Rungby J, Danscher G. Localization of exogenous silver in brain and spinal cord of silver exposed rats. Acta Neuropathol 1983a;60:92-8.
28. Lansdown AB. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol 2007;37:237-50.
29. Rungby J, Slomianka L, Danscher G, Andersen AH, West MJ. A quantitative evaluation of the neurotoxic effect of silver on the volumes of the components of the developing rat hippocampus. Toxicology 1987;43:261-8.
30. Powers CM, Wrench N, Ryde IT, Smith AM, Seidler FJ, Slotkin TA. Silver impairs neurodevelopment: studies in PC12 cells. Environ Health Perspect 2010;118:73-9.
31. Lewis CG, Sunderman FW Jr. Metal carcinogenesis in total joint arthroplasty. Animal models. Clin Orthop Relat Res 1996;329:264-8.
32. Memoli VA, Urban RM, Alroy J, Galante JO. Malignant neoplasms associated with orthopedic implant materials in rats. J Orthop Res 1986;4:346-55.
33. Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL. TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis. Biomaterials 2003;24:383-91.
34. Larsen A, Kolind K, Pedersen DS, Doering P, Pedersen MO, Danscher G et al. Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury. Histochem Cell Biol 2008;130:681-92.
35. Pedersen MO, Larsen A, Pedersen DS, Stoltenberg M, Penkova M. Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. Histol Histopathol 2009;24:573-86.
36. Pedersen MO, Larsen A, Pedersen DS, Stoltenberg M, Penkowa M. Metallic gold reduces TNFalpha expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury. Brain Res 2009;19:103-13.
37. Wilkie DA, Gemensky-Metzler AJ. Agents for intraocular surgery. Vet Clin North Am Small Anim Pract 2004;34:801-23.
38. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego, 2001.
39. Stoltenberg M, Danscher G. Histochemical differentiation of autometallographically traceable metals (Au, Ag, Hg, Bi, Zn). Protocols for chemical removal of separate autometallographic metal clusters in Epon sections. Histochem J 2000;32:645-52.
40. Gasull T, Rebollo DV, Romero B, Hidalgo J. Development of a competitive double antibody radioimmunoassay for rat metallothionein. J Immunoassay 1993;14:209-25.
41. Penkowa M, Hidalgo J, Moos T. Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamide. Brain Res 1997;774:256-9.
42. Penkowa M, Moos T, Carrasco J, Hadberg H, Molinero A, Bluethmann H et al. Strongly compromised inflammatory response to brain injury in Interleukin-6-deficient mice. Glia 1999;25:343-57.
43. Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J et al. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol 2003;181:130-48.
44. Stata Release 11. Statistical Software. StataCorp LP, College Station, 2009.
45. Locht LJ, Smidt K, Rungby J, Stoltenberg M, Larsen A. Uptake of silver from metallic silver surfaces induces cell death and a pro-inflammatory response in cultured J774 macrophages. Accepted Histology and Histopathology.
46. Catelas I, Petit A, Vali H, Fragiskatos C, Meilleur R, Zukor DJ et al. Quantitative analysis of macrophage apoptosis vs. necrosis induced by cobalt and chromium ions in vitro. Biomaterials 2005;26:2441-53.
47. Huk OL, Catelas I, Mwale F, Antoniou J, Zukor DJ, Petit A. Induction of apoptosis and necrosis by metal ions in vitro. J Arthroplasty 2004;19:84-7.
48. Petit A, Mwale F, Zukor DJ, Catelas I, Antoniou J, Huk OL. Effect of cobalt and chromium ions on bcl-2, bax, caspase-3, and caspase-8 expression in human U937 macrophages. Biomaterials 2004;25:2013-8.
49. Terman A, Kurz T, Gustafsson B, Brunk UT. Lysosomal labilization. IUBMB Life 2006;58:531-9.
50. Miura N, Shinohara Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun 2009;390:733-7.
51. Park EJ, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 2010;24:872-8.
52. Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 2009;236:310-8.
53. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008;209:294-301.
54. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007;8:57-69.
55. Rungby J, Danscher G. Neuronal accumulation of silver in brains of progeny from argyric rats. Acta Neuropathol 1983;61:258-62.
56. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. J Neurosci 1997;17:3664-74.
57. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006;129:2761-72.
58. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005;11:400-7.
59. Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010;7:22-30.
60. Pedersen MO, Jensen R, Pedersen DS, Skjolding AD, Hempel C, Maretty L et al. Metallothionein-I+II in neuroprotection. BioFactors 2009;35:315-25.
61. Stankovic RK, Chung RS, Penkowa M. Metallothioneins I and II: neuroprotective significance during CNS pathology. Int J Biochem Cell Biol 2007;39:484-9.
62. Chung RS, Penkowa M, Dittmann J, King CE, Bartlett C, Asmussen JW et al. Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J Biol Chem 2008;30:15349-58.
63. Penkowa M. Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J 2006;273:1857-70.
64. Kadhim HJ, Duchateau J, Sébire G. Cytokines and brain injury: invited review. J Intensive Care Med 2008;23:236-49.
65. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci 1999;19:8182-98.